New Virginia Tech Institute to Focus on Neuroscience with Molecular Genetics, Informatics Components | GenomeWeb

By Alex Philippidis

NEW YORK (GenomeWeb News) – The newly-named founding executive director of the Virginia Tech Carilion Research Institute said it will begin operations this fall by ramping up a program in neuroscience — his longtime research focus, and a specialty of the university — to be followed over the first two years by programs in cardiovascular science and cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.